Telix Pharmaceuticals Ltd 20-F for FY2025
Telix Pharmaceuticals Ltd (TLX)
20-F
2026-02-20
For: 2025-12-31
View Original
Added on
April 07, 2026
About this 20-F
Telix Pharmaceuticals Ltd filed this 20-F on February 20, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $803.79M
- up 55.6% from $516.55M a year earlier
- Net loss
- $7.13M
- compared with net income of $33.69M a year earlier
- Diluted EPS
- -$0.02
- compared with $0.10 a year earlier